After completing the 12-month PGY-2 Pharmacy Residency in Investigational Drugs and Research at Mayo Clinic Hospital — Rochester, you will be a proficient independent practitioner capable of providing advanced knowledge in supporting clinical trials through investigational drug management involving human subjects.

The purpose of the PGY-2 Pharmacy Residency in Investigational Drug Services (IDS) and Research at Mayo Clinic Hospital — Rochester is to build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY-2 residencies provide you with opportunities to function independently as a practitioner by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care and safety or other advanced practice settings.

Residents who successfully complete a PGY-2 in IDS and research are prepared for roles related to investigational drug management, protocol review and analysis, and interprofessional networking with clinical trial personnel.

Program highlights

The program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent clinical pharmacist. As a PGY-2 investigational drugs and research resident, you:

• Develop expertise, knowledge, and skills in research pharmacy practice through protocol setup and investigational drug dispensing
• Contribute to an interdisciplinary healthcare team by offering patient-specific interventions related to protocol inclusion/exclusion criteria and concomitant drug therapies
• Provide investigational drug information to study teams and other interdisciplinary professionals in an environment based on teamwork and mutual respect
• Enhance your skills in conducting clinical research and quality-improvement initiatives
• Strengthen your communication skills by presenting formal and informal lectures, writing a professional manuscript, and leading interdisciplinary discussions
• Develop pharmacy practice management skills by leading various committees, establishing policies and understanding the pharmacy practice philosophy
• Network with fellow pharmacy residents and practicing clinicians through professional membership and conferences

The PGY-2 Investigational Drugs and Research Residency provides opportunities for general training in numerous areas of practice. During each learning experience, you work closely with preceptors, highly qualified pharmacists, providers, and other allied healthcare professionals.

Program history

The PGY-2 Pharmacy Residency in Investigational Drugs and Research at Mayo Clinic in Rochester, Minnesota, is a newly developed program accepting our first resident for the 2025-2026 residency year. Our program has been approved for pre-candidate status through ASHP and anticipates being accredited upon graduation of our first resident. 

We currently have a well-established and accredited PGY-1 General Residency and 10 PGY-2 programs that have guided us in the creation of our Investigational Drugs and Research Residency. This residency program will be continuously evaluated for improvement opportunities to ensure that graduates make a seamless transition into clinical research practice. One candidate will be selected each year.